Regulatory Resources
We know that there are many regulatory resources and guidance out there when developing your protocol and conducting your research. Here, we have organized some of the most often-used regulatory sites into one area for your reference.
We know that there are many regulatory resources and guidance out there when developing your protocol and conducting your research. Here, we have organized some of the most often-used regulatory sites into one area for your reference.
Office of Human Research Protections (OHRP)
Food and Drug Administration (FDA)
- Adverse Event Reporting
- FDA Guidance for Clinical Investigators, Sponsors, and IRBs Adverse Event Reporting to IRBs — Improving Human Subject Protection
- FDA webpage: “What is a Serious Adverse Event?”
- Drug label changes per FDA-How to Receive Email Updates About FDA Drug Label Changes
- FDA Guidance: Expanded Access to Drugs for Treatment Use (updated 2017)
- How to submit an Expanded Access Request (FDA)
- Individual Expanded Access Applications: Form 3926 (2017)
- 21 CFR 50-Informed Consent and Children
- 21 CFR 56- Institutional Review Boards
- 21 CFR 312-INDs
- 21 CFR 812- IDEs
- Emergency IND FDA Information Sheet
NIH Resource Links
- Active Protocol Consents
- BTRIS
- Clinical Center
- Clinical Center Bioethics
- Genetic Information Nondiscrimination Act of 2008
- Genomic Data Sharing
- Human Subject Protection Unit Consult Service
- Inclusion Policies for Research Involving Human Subjects
- Institutional Biosafety Committee (IBC)
- Intramural Research Program (OIR)
- Intramural Research Sourcebook
- Medical Administrative Series Policies
- NEO Conflict of Interest Policy Page
- NIH Human Embryonic Stem Cell Registry
- NIH Guidelines for Human Stem Cell Research (NIH policy for research using hESCs and iPSCs)
- NIH Stem Cell Website
- NIH Manual - 1743-3000 Records Retention
- NIH Manual - 2300-308-4 - NIH On-Site Research Collaborator Policy
- NIH Manual- 2300-630-3: Employees participating in Research
- NIH Manual- 2809 Social Media Appendix A
- NIH Manual - 3014 HRPP
- NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
- Office of Clinical Research
- Office of Protocol Services
- Office of Technology Development
- OIR Policy Page: Human Embryonic Stem Cell Checklist and Induced Pluripotent Stem Cell Registration
- Paperwork Reduction Act Clearance System (PRACS)
- Privacy Act